Tandem autologous stem cell transplantation in multiple myeloma after high-dose chemotherapy with two separate collections: single institution experience
| Main Authors: | Vranovský, Andrej, 1966- (Author), Lakota, J. (Author), Drgoňa, Ľuboš, 1967- (Author), Ladická, Miriam (Author), Ballova, V. (Author) |
|---|---|
| Format: | Article |
| Language: | English |
Predplatné
Kliknite na „Pozri predplatné“.
Similar Items
Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation
by: Oltova, A., et al.
by: Oltova, A., et al.
Autologous stem cell transplantation in first-line treatment of high-risk aggressive non-Hodgkin's lymphoma
by: Vranovský, Andrej, 1966-, et al.
by: Vranovský, Andrej, 1966-, et al.
Antiemetic efficacy of the three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma
by: Slabý, J., et al.
by: Slabý, J., et al.
Autologous stem cell transplantation with selected CD34+ cells and unmanipulated peripheral blood stem cells in patients with relapsed and refractory Hodgkin's lymphoma: a single centre experience
by: Vranovský, Andrej, 1966-, et al.
by: Vranovský, Andrej, 1966-, et al.
Similar Items
-
Negative prognostic significance of two or more cytogenetic abnormalities in multiple myeloma patients treated with autologous stem cell transplantation
by: Oltova, A., et al. -
Autologous stem cell transplantation in first-line treatment of high-risk aggressive non-Hodgkin's lymphoma
by: Vranovský, Andrej, 1966-, et al. -
Antiemetic efficacy of the three serotonin antagonists during high-dose chemotherapy and autologous stem cell transplantation in malignant lymphoma
by: Slabý, J., et al. -
Autologous stem cell transplantation with selected CD34+ cells and unmanipulated peripheral blood stem cells in patients with relapsed and refractory Hodgkin's lymphoma: a single centre experience
by: Vranovský, Andrej, 1966-, et al. -
Health-related quality of life in multiple myeloma survivors treated with high dose chemotherapy followed by autologous peripheral blood progenitor cell transplantation: a retrospective analysis
by: Slovackova, B., et al.


